Evidence map›Paper›PMID 38611770›Full record

ArticleMolecules (Basel, Switzerland)2024

Development and Validation of a High-Performance Liquid Chromatography Method to Quantify Marker Compounds in

Hye-Youn Kim, Cho-Een Kim, Dool-Ri Oh, Yonguk Kim, Chul-Yung Choi, Jaeyong Kim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hye-Youn KimJeonnam Institute of Natural Resources Research (JINR), Jeonnam Bio Foundation, Jangheung-gun 59338, Republic of Korea.ORCID 0000-0003-2312-7437
Cho-Een KimJeonnam Institute of Natural Resources Research (JINR), Jeonnam Bio Foundation, Jangheung-gun 59338, Republic of Korea.ORCID 0000-0003-1024-6656
Dool-Ri OhJeonnam Institute of Natural Resources Research (JINR), Jeonnam Bio Foundation, Jangheung-gun 59338, Republic of Korea.ORCID 0000-0002-4348-6050
Yonguk KimJeonnam Institute of Natural Resources Research (JINR), Jeonnam Bio Foundation, Jangheung-gun 59338, Republic of Korea.ORCID 0000-0003-3026-0893
Chul-Yung ChoiBK21 FOUR Educational Research Group for Age-Associated Disorder Control Technology, Institute of Well-Aging Medicare, Department of Integrative Biological Sciences, Chosun University, Gwangju 61452, Republic of Korea.ORCID 0000-0003-2006-635X
Jaeyong KimJeonnam Institute of Natural Resources Research (JINR), Jeonnam Bio Foundation, Jangheung-gun 59338, Republic of Korea.ORCID 0000-0003-4810-7635
Jeonnam Bioindustry Foundation · KRChosun University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS), a common gastrointestinal disorder worldwide, is characterized by chronic abdominal pain, bloating, and disordered defecation. IBS is associated with several factors, including visceral hypersensitivity, gut motility, and gut-brain interaction disorders. Because currently available pharmacological treatments cannot adequately improve symptoms and may cause adverse effects, the use of herbal therapies for managing IBS is increasing.

Indexed as

Brain DiseasesIrritable Bowel SyndromeAnimalsChromatography, High Pressure LiquidDiarrheaDisease Models, AnimalLysimachiaMethanolMicePlant ExtractsSerotoninMethanolPlant ExtractsSerotonindiarrheahigh-performance liquid chromatographyirritable bowel syndromeLysimachia vulgaris var. davuricamarker compoundsvalidation

Identifiers

PMID38611770
PMCPMC11013019
OpenAlexW4393219540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.